Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China
Clinical trial NCT01726439 · COMPLETED
Trial details
- NCT number
- NCT01726439
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-12-31
- Enrollment
- 3434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.